buparvaquone has been researched along with l 683590 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, W; Dobbelaere, D; Eichhorn, M; Galley, Y; Glaser, I; Hagens, G | 1 |
1 other study(ies) available for buparvaquone and l 683590
Article | Year |
---|---|
Jun NH2-terminal kinase is constitutively activated in T cells transformed by the intracellular parasite Theileria parva.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antiprotozoal Agents; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Activation; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Indoles; JNK Mitogen-Activated Protein Kinases; Kinetics; Lymph Nodes; Lymphocyte Activation; Maleimides; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Naphthoquinones; Polyenes; Protein Kinase C; Protein Kinases; Receptor-CD3 Complex, Antigen, T-Cell; Sirolimus; T-Lymphocytes; Tacrolimus; Theileria parva | 1997 |